Group One Trading, L.P. Aridis Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$0.16 - $0.4 $176 - $440	1,100 Added 88.92%	2,337 $0
Q1 2023 May 12, 2023	SELL	$0.31 - $1.5 $609 - $2,947	-1,965 Reduced 61.37%	1,237 $0
Q4 2022 Feb 09, 2023	SELL	$0.81 - $1.18 $12,390 - $18,050	-15,297 Reduced 82.69%	3,202 $3,000
Q3 2022 Nov 09, 2022	SELL	$0.73 - $2.47 $2,217 - $7,501	-3,037 Reduced 14.1%	18,499 $17,000
Q2 2022 Aug 11, 2022	SELL	$0.91 - $1.7 $5,032 - $9,401	-5,530 Reduced 20.43%	21,536 $24,000
Q1 2022 May 12, 2022	BUY	$1.33 - $2.59 $35,997 - $70,100	27,066 New	27,066 $48,000

50.2K

Ticker ARDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,701,600
Description
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.